Skip to Content
Contact Form Map & Directions Videos

CDC: Autism Rates Jump 30 Percent, Boys Most Affected

03/31/2014
Announcement
BY

When the mercury-based preservative thimerosol was slowly removed from childhood vaccines it was assumed that the astonishing rates of autism would decline. Autism is a brain abnormalty that makes children socially awkward if not totally withdrawn. For years it was suspected that mercury toxicity was behind cases of autism, estimated […]

Read More

The Penalty Game

03/31/2014
Articles
BY

Johnson and Johnson (J&J) and its subsidiary Janssen Pharmaceuticals have been dealing with multiple lawsuits stemming from its drug Risperdal. Shortly after dodging a $1.2 billion judgment in Arkansas, J&J has returned its focus to the multidistrict litigation (MDL) currently pending in Pennsylvania. The company is now trying to shield […]

Read More

When Money Influences Medicine

03/27/2014
Articles
BY

The Wall Street Journal reports on conflict of interest disclosures that have evolved as a result of transvaginal mesh (TVM) lawsuits filed against healthcare giant, Ethicon, a division of Johnson & Johnson. Amid the hundreds of thousands of pages of documents provided in the 17,000 cases filed in federal court […]

Read More

J&J Gets $1.2 Billion Pass on Risperdal Fine

03/27/2014
Defective Drugs
BY

Two years ago, healthcare giant Johnson & Johnson was facing a $1.2 billion judgment after a jury determined J&J concealed the risks of its antipsychotic drug Risperdal while it aggressively and improperly marketed it off-label. At the time it was the largest state fine over the mismarketing of Risperdal and […]

Read More

Brenda Fulmer Featured in Trial Magazine

03/25/2014
Announcement
BY

Congratulations, Brenda! We’ve reprinted the article below. Reprinted with permission of Trial (March 2014) Copyright American Association for Justice, formerly Association of Trial Lawyers of America (ATLA®) Gender equity in the law March 2014, Volume 50, No. 3 Sidebar: Brenda Fulmer: Working hard and staying true  Courtney L. Davenport When […]

Read More

Living Off the Label

03/24/2014
Articles
BY

Doctors and physicians are given a great deal of discretion when it comes to prescribing drugs for uses other than those indicated by the FDA. This is known as “off-label” use. The FDA, realizing the danger of off-label promotion in its 2009 guidance, has set forth rules to restrict the […]

Read More

Drug Supplement Endangers Kids

03/19/2014
Articles
BY

It is a supplement used to treat children with a genetic disorder but instead has hospitalized at least one child. The Food and Drug Administration (FDA) reports lots of L-citrulline, sold by Medisca, had none of the active drug. The Plattsburgh, N.Y.-based compounding company was forced to recall eight lots […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker